Effects of tramadol and buprenorphine on select immunologic factors in a cecal ligation and puncture model

Shock

Volumn 34, Issue 3, 2010, Pages 250-260

  Hugunin, Kelly M S ^a   Fry, Christopher ^a   Shuster, Katherine ^a   Nemzek, Jean A ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

analgesia; animal welfare; cytokines; Opioids; sepsis models

Indexed keywords

BUPRENORPHINE; CD69 ANTIGEN; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; RINGER LACTATE SOLUTION; TRAMADOL; TUMOR NECROSIS FACTOR ALPHA;

AIRWAY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL WELFARE; ARTICLE; CECAL LIGATION AND PUNCTURE MODEL; CELL COUNT; CONTROLLED STUDY; DRUG EFFECT; DRUG MEGADOSE; EXPERIMENTAL MODEL; FEMALE; IMMUNE SYSTEM; INFLAMMATION; LOW DRUG DOSE; MORTALITY; MOUSE; NATURAL KILLER CELL; NONHUMAN; PERITONEUM; SEPSIS;

ANIMAL WELFARE; ANIMALS; ASCITIC FLUID; BRONCHOALVEOLAR LAVAGE FLUID; BUPRENORPHINE; CECUM; CELL COUNT; CYTOKINES; FEMALE; INTESTINAL PERFORATION; LEUKOCYTE COUNT; LIGATION; MACROPHAGES; MICE; MICE, INBRED ICR; MODELS, ANIMAL; NARCOTICS; PAIN; PAIN PERCEPTION; PERITONITIS; SHOCK, SEPTIC; TRAMADOL;

EID: 77955942788     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3181cdc412     Document Type: Article

References (29)

1. Deitch EA: Rodent models of intra-abdominal infection. Shock 24(Suppl 1): 19-23, 2005.
2. Buras JA, Holzmann B, Sitkovsky M: Animal models of sepsis: setting the stage. Nat Rev Drug Discov 4:854-865, 2005.
3. Hubbard WJ, Choudhry M, Schwacha MG, Kerby JD, Rue LW 3rd, Bland KI, Chaudry IH: Cecal ligation and puncture. Shock 24:52-57, 2005.
4. Nemzek JA, Hong-Yan X, Minard AE, Bolgos GL, Remick DG: Humane endpoints in shock research. Shock 21:17-25, 2004.
5. Public Health Service: Public Health Service Policy on Humane Care and Use of Laboratory Animals. Washington, DC: US Department of Health and Human Services, p 13, 2002.
6. Consales G, De Gaudia AR: Sepsis-associated encephalopathy. Minerva Anestesiol 71:39-52, 2005.
7. Molina PE: Opioids and opiates: analgesia with cardiovascular, haemody-namic and immune implications in critical illness. J Intern Med 259:138-154, 2006.
8. Vallejo R, De Leon-Casasola O, Benyamin R: Opioid therapy and immuno-suppression: a review. Am J Ther 11:354-365, 2004.
9. Hilburger ME, Adler MW, Truant AL, Meissler JJ Jr, Satishchandran V, Rogers TJ, Eisenstein TK: Morphine induces sepsis in mice. J Infect Dis 176: 183-188, 1997.
10. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR: Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29:1303-1310, 2001.
11. Vender JS, Szokol J, Murphy GS, Nitsun M: Sedation, analgesia, and neuro-muscular blockade in sepsis: an evidence-based review. Crit Care Med 32: 554-561, 2004.
12. Toth LA: Defining the moribund condition as an experimental endpoint for animal research. ILAR J 41:72-79, 2000.
13. Interagency Research Animal Committee: US Government Principles for the Utilization and Care of Vertebrate Animals Used in Testing, Research, and Training. Federal Register, May 20, 1985. Washington, DC: Office of Science and Technology, 1985.
14. Sacerdote P: Opioids and the immune system. Palliat Med 20:9-15, 2006.
15. Remick DG, Bolgos GR, Siddiqui J, Shin J, Nemzek JA: Six at six: interleukin-6 measured at 6 h after the initiation of sepsis predicts mortality over 3 days. Shock 17:463-1367, 2002.
16. Hawk CT, Leary S, Morris T: Formulary for Laboratory Animals, 3rd ed. Ames, IA: Wiley-Blackwell Inc, p 19, 2005.
17. Sacerdote P, Bianchi M, Manfredi B, Panerai AE: Effects of tramadol on immune responses and nociceptive thresholds in mice. Pain 72:325-330, 1997.
18. Shirzad H, Shahrani M, Rafieian-Kopaei M: Comparison of morphine and tramadol effects on phagocytic activity of mice peritoneal phagocytes in vivo. Int Immunopharmacol 9:968-970, 2009.
19. Barcia E, Martin A, Luz Azuara M, Sanchez Y, Negro S: Tramadol and hyoscine N-butyl bromide combined in infusion solutions: compatibility and stability. Support Care Cancer 15:57-62, 2007.
20. Nemzek JA, Siddiqui J, Remick DG: Development and optimization of cytokine ELISAs using commercial antibody pairs. J Immunol Methods 255: 149-157, 2001.
21. Martucci C, Panerai AE, Sacerdote P: Chronic fentanyl or buprenorphine infusion in the mouse: similar analgesic profile but different effects on immune responses. Pain 110:385-392, 2004.
22. Carrigan KA, Saurer TB, Ijames SG, Lysle DT: Buprenorphine produces naltrexone reversible alterations of immune status. Int Immunopharmacol 4:419-428, 2004.
23. Piersma FE, Daemen MARC, Bogaard AE, Buurman WA: Interference of pain control employing opioids in in vivo immunological experiments. Lab Anim 33:328-333, 1999.
24. Franchi S, Panerai AE, Sacerdote P: Buprenorphine ameliorates the effect of surgery on hypothalamus-pituitary-adrenal axis, natural killer cell activity and metastatic colonization in rats in comparison with morphine or fentanyl treatment. Brain Behav Immun 21:767-774, 2007.
25. Wang G, Weng Y, Ishiguro Y, Sakamoto H, Morita S: The effect of tramadol on serum cytokine response in patients undergoing pulmonary lobectomy. J Clin Anesth 17:444-450, 2005.
26. Gaspani L, Bianchi M, Limiroli E, Panerai AE, Sacerdote P: The analgesic drug tramadol prevents the effect of surgery on natural killer cell activity and metastatic colonization in rats. J Neuroimmunol 129:18-24, 2002.
27. Topcu I, Ekici NZ, Isik R, Sakarya M: The effects of tramadol and fenta-nyl on gastrointestinal motility in septic rats. Anesth Analg 102:876-881, 2006.
28. Zeerleder S, Hack CE, Caliezi C, van Mierlo G, Eerenberg-Belmer A, Wolbin A, Wuillenmin WA: Activated cytotoxic T cells and NK cells in severe sepsis and septic shock and their role in multiple organ dysfunction. Clin Immunol 116:158-165, 2005.
29. Deitch EA: Animal models of sepsis and shock: a review and lessons learned. Shock 9:1-11, 1998.